Use of a clinical pathway in laparoscopic gastrectomy for gastric cancer

Table 4 Clinicopathological characteristics of patients who underwent total laparoscopic gastrectomy (intracorporeal anastomosis) and laparoscopic assisted gastrectomy (extracorporeal anastomosis) n (%)

Variables	Intra (n = 2345)	Extra (n = 2455)	P value1
Sex			0.118
Male	1453 (61.96)	1467 (59.76)
Female	892 (38.04)	988 (40.24)
Age (yr)			0.110
≤ 65	1716 (73.18)	1846 (75.19)
> 65	629 (26.82)	609 (24.81)
BMI (kg/m2)			< 0.001
≤ 25	1490 (63.54)	1835 (74.75)
> 25	855 (36.46)	620 (25.25)
Resection			< 0.001
Distal	2018 (86.06)	2200 (89.61)
Total	327 (13.94)	255 (10.39)
Combined OP			0.958
None	2214 (94.41)	2317 (94.38)
Yes	131 (5.59)	138 (5.62)
Event during OP			0.002
None	2321 (98.98)	2402 (97.84)
Yes	24 (1.02)	53 (2.16)
Number of comorbidities			< 0.001
0	1477 (62.99)	1719 (70.02)
1	588 (25.07)	549 (22.36)
2 and more	280 (11.94)	187 (7.62)
ASA			< 0.001
1	1404 (59.87)	1621 (66.03)
2	822 (35.05)	727 (29.61)
3	119 (5.07)	107 (4.36)
Abd OP history			0.008
None	1949 (83.11)	2108 (85.87)
Yes	396 (16.89)	347 (14.13)
TNM stage			< 0.001
I	2066 (88.10)	2314 (94.26)
II	197 (8.40)	117 (4.77)
III	82 (3.50)	24 (0.98)

¹χ² test. Intra: Intracorporeal anastomosis; Extra: Extracorporeal anastomosis; BMI: Body mass index; OP: Operation; ASA: American Society of Anesthesiologists; Abd: Abdominal.